Literature DB >> 6089997

Primary liver cancer in Japan. The Liver Cancer Study Group of Japan.

.   

Abstract

The Liver Cancer Study Group of Japan statistically analyzed 2396 cases of primary liver cancer diagnosed from January 1, 1978 to December 31, 1979 in over 500 hospitals throughout the country. They comprised 1047 cases of hepatocellular carcinoma, 93 of cholangiocarcinoma, 9 of mixed carcinoma, 16 of hepatoblastoma, and 33 others. In 1198 cases (50%) a histologic diagnosis was available. The survey and analysis, based mostly on the histologically proven cases, describe the gross anatomic and histologic features of the tumors, grade of anaplasia and growth patterns of the tumor cells, pathology in noncancerous portions of the liver, distant metastases, past medical history, frequency of hepatitis in the past history, frequency of positive HBsAg and anti-HBs, age distribution, subjective symptoms, radiographic features (angiogram, scintiscan, computed tomography), ultrasonography, surgical procedures, extent of hepatic resection, and survival.

Entities:  

Mesh:

Year:  1984        PMID: 6089997     DOI: 10.1002/1097-0142(19841015)54:8<1747::aid-cncr2820540846>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma.

Authors:  H Ishizu
Journal:  Jpn J Surg       Date:  1989-11

2.  Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report.

Authors:  H Wakabayashi; S Okada; T Maeba; H Maeta
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Hepatectomy for huge hepatocellular carcinoma in 634 cases.

Authors:  Xiao-Ping Chen; Fa-Zu Qiu; Zai-De Wu; Bi-Xiang Zhang
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

4.  Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial.

Authors:  E C Lai; T K Choi; S W Tong; G B Ong; J Wong
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

5.  A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma.

Authors:  S Imaoka; Y Sasaki; T Shibata; M Fujita; H Kasugai; J Kojima; S Ishiguro; H Ohigashi; O Ishikawa; I Fukuda
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Active inflammatory change of the liver as a cause of postoperative hepatic failure.

Authors:  M Sakurai; J Okamura; C Kuroda; T Yamada
Journal:  Jpn J Surg       Date:  1986-11

7.  Hepatitis B virus infection in liver cirrhosis and hepatocellular carcinoma in Jakarta Indonesia.

Authors:  H A Sulaiman
Journal:  Gastroenterol Jpn       Date:  1989-08

8.  Hepatic resection for hepatocellular carcinoma.

Authors:  M Suenaga; A Nakao; A Harada; T Nonami; Y Okada; H Sugiura; S Uehara; H Takagi
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

9.  Intraoperative sonography of hepatocellular carcinoma: detection of lesions and validity in surgical resection.

Authors:  B I Choi; J K Han; I S Song; C W Kim; M C Han; S T Kim; H S Lee; C Y Kim; Y I Kim
Journal:  Gastrointest Radiol       Date:  1991

10.  A case of combined hepatocellular-cholangiocarcinoma with underlying schistosomiasis.

Authors:  Chang Kyun Hong; Jin Mo Yang; Bong Koo Kang; Jin Dong Kim; Young Chul Kim; U-Im Chang; Jin Young Yoo
Journal:  Korean J Intern Med       Date:  2007-12       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.